What is the global market size of the Transcatheter Embolization and Occlusion Devices Market?

Global Transcatheter Embolization and Occlusion Devices Market size was valued at USD 5.76 billion in 2021 and is poised to grow from USD 5.1 billion in 2022 to USD 13.47 billion by 2030, growing at a CAGR of 9.89% in the forecast period (2023-2030).

Who are the key vendors in the Global Transcatheter Embolization and Occlusion Devices Market?

The global transcatheter embolization and occlusion devices market is highly competitive and characterised by the presence of several major players. These companies are engaged in continuous research and development activities to introduce innovative products and gain a competitive edge in the market. The competitive landscape is shaped by factors such as product offerings, technological advancements, strategic collaborations, and geographical presence. 'Medtronic (Ireland)', 'Boston Scientific Corporation (United States)', 'Stryker Corporation (United States)', 'Terumo Corporation (Japan)', 'Johnson & Johnson (United States)', 'Cook Medical (United States)', 'Abbott Laboratories (United States)', 'Merit Medical Systems, Inc. (United States)', 'Penumbra, Inc. (United States)', 'BTG International Ltd. (United Kingdom)', 'Cardiva Medical, Inc. (United States)', 'Cook Group Incorporated (United States)', 'Balt International (France)', 'Edwards Lifesciences Corporation (United States)', 'Penumbra, Inc. (United States)', 'Sirtex Medical Limited (Australia)', 'Teleflex Incorporated (United States)', 'Acandis GmbH (Germany)', 'AngioDynamics, Inc. (United States)', 'Gore Medical (United States)'

Transcatheter Embolization and Occlusion Devices Market Size, Share, Growth Analysis, By Type(Coil [Pushable Coils, Detachable Coils], Non-Coil [Flow Diverting Devices, Embolization Particles), By Application(Peripheral Vascular Disease [Arterial Blockage, Venous Blood clot, Others], Oncology [Liver Cancer), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2295 | Region: Global | Published Date: October, 2024
Pages: 157 | Tables: 66 | Figures: 75

Transcatheter Embolization and Occlusion Devices Market Insights

Global Transcatheter Embolization and Occlusion Devices Market size was valued at USD 4.5 billion in 2022 and is poised to grow from USD 4.82 billion in 2023 to USD 8.41 billion by 2031, growing at a CAGR of 7.20% during the forecast period (2024-2031).

The global transcatheter embolization and occlusion devices market has been experiencing significant growth in recent years. Transcatheter embolization and occlusion devices are minimally invasive medical devices used to block or reduce blood flow to abnormal vessels or tissues within the body. These devices are widely used in the treatment of various medical conditions, including tumours, aneurysms, and vascular malformations. Moreover, the increasing geriatric population worldwide is driving the demand for transcatheter embolization and occlusion devices. Elderly individuals are more prone to cardiovascular diseases and various types of cancer, necessitating the use of minimally invasive treatment options. Additionally, the rising healthcare expenditure and improving healthcare infrastructure in emerging economies are further fueling market growth.

Transcatheter Embolization and Occlusion Devices Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The global transcatheter embolization and occlusion devices market is highly competitive and characterised by the presence of several major players. These companies are engaged in continuous research and development activities to introduce innovative products and gain a competitive edge in the market. The competitive landscape is shaped by factors such as product offerings, technological advancements, strategic collaborations, and geographical presence. 'Boston Scientific Corporation (US) ', 'Terumo Corporation (Japan) ', 'Medtronic (Ireland) ', 'Abbott (US) ', 'Cook Medical Inc. (US) ', 'Penumbra, Inc. (US) ', 'Cerenovus (a subsidiary of Johnson & Johnson) (US) ', 'Guerbet S.A. (France) ', 'Merit Medical Systems, Inc. (US) ', 'AngioDynamics, Inc. (US) ', 'B. Braun Melsungen AG (Germany) ', 'Humares (Germany) ', 'Inari Medical, Inc. (US) ', 'MicroVention, Inc. (US) ', 'Endospan Ltd. (Israel) ', 'Teleflex Incorporated (US) ', 'Kaneka Corporation (Japan) ', 'Abbott Vascular (a division of Abbott Laboratories) (US) ', 'SentreHEART, Inc. (US) ', 'Vascular Technologies (US)'

The global market for transcatheter embolization and occlusion devices is witnessing growth due to the rising demand for minimally invasive treatment options. Patients and medical professionals are increasingly opting for these procedures because they offer benefits such as faster recovery times, shorter hospital stays, and reduced risk of complications. The preference for minimally invasive procedures is a major driver behind the increasing demand for transcatheter embolization and occlusion devices.

Adoption of New Technologies: New technologies are being developed that offer improved safety and efficacy, and these new technologies are expected to drive market growth in the coming years. In addition to the increasing adoption of new technologies, other key market trends for transcatheter embolization and occlusion devices include the increasing prevalence of chronic diseases, the rising demand for minimally invasive procedures, and the increasing adoption of reimbursement policies for these devices. As the market continues to grow, we can expect to see more innovation in the transcatheter embolization and occlusion devices industry, and this innovation is expected to help these devices become even more effective in treating a variety of medical conditions.

North America has emerged as the most dominant market for transcatheter embolization and occlusion devices. This can be attributed to the well-established healthcare infrastructure, high adoption rate of advanced medical technologies, and favourable reimbursement policies in countries like the United States and Canada. The presence of key market players and ongoing research and development activities in the region further contribute to its dominance.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Transcatheter Embolization and Occlusion Devices Market Insights

Transcatheter Embolization and Occlusion Devices Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Transcatheter Embolization and Occlusion Devices Market?

Who are the key vendors in the Transcatheter Embolization and Occlusion Devices Market?

What is the key driver of Transcatheter Embolization and Occlusion Devices Market?

What is the key market trend for Transcatheter Embolization and Occlusion Devices Market?

Which region accounted for the largest share in Transcatheter Embolization and Occlusion Devices Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300